rituximab

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nephrotic Syndrome in Children, Rituximab Trial in Hangzhou (Rituximab, Steroid)

Not yet recruiting
  • Nephrotic Syndrome in Children
  • Rituximab
  • Hangzhou, Zhejiang, China
    Children's Hospital, Zhejiang University School of Medicine
Feb 9, 2023

Refractory Myasthenia Gravis, Rituximab Trial in Guangzhou (Rituximab)

Recruiting
  • Refractory Myasthenia Gravis
  • Rituximab
  • Guangzhou, China
    First Affiliated Hospital, Sun Yat-Sen University
Apr 26, 2022

Rituximab in Children With Blood Diseases

Not yet recruiting
  • Rituximab
  • +2 more
  • (no location specified)
Apr 8, 2022

COVID19 Vaccination, Rituximab, Immunosuppression Trial in Bern (History of exposure to anti-CD20 treatment since 01/01/2010,

Recruiting
  • COVID19 Vaccination
  • +2 more
  • History of exposure to anti-CD20 treatment since 01/01/2010
  • Completion of COVID19 vaccine at least 4 weeks ago
  • Bern, BE, Switzerland
    University Hospital Bern Inselspital
May 27, 2021

Diffuse Large B-cell Lymphoma, Rituximab, Toripalimab Trial in Beijing (Toripalimab combine with Rituximab)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • +2 more
  • Toripalimab combine with Rituximab
  • Beijing, China
    Cancer Institute/Hospital, Chinese Academy of Medical Sciences &
Jun 12, 2020

Chidamide, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse Trial in Shanghai (Chidamide combined with R-GDP)

Unknown status
  • Chidamide
  • +15 more
  • Chidamide combined with R-GDP
  • Shanghai, Shanghai, China
  • +1 more
Dec 12, 2017